Regular eye exams are important in detecting early signs of diabetic retinopathy to prevent vision loss. Since diabetic retinopathy doesn’t cause symptoms in its early stages, diagnostic testing can ...

LONDON – Long-established, but often forgotten, primary care tools, including the swinging light test and the lipid-lowering drug fenofibrate, may help detect early worsening of diabetic retinopathy ...

SOUTH SIOUX CITY, Neb. (KTIV) -November is National Diabetes Month. The Siouxland Community Health Center is doing its part to help patients by using new technology to screen for a condition that ...

Helping prevent eye damage from diabetes involves keeping blood sugar, blood pressure, and cholesterol levels within target ranges. Regular exercise and yearly eye exams are also important. Diabetes ...

Diabetes can affect eye health, but is a danger which is often overlooked. Here are all the risks to the eye, warning signs ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

The five human senses include sight, hearing, smell, taste, and touch. While each of these matter for different reasons, they aren't perceived as being equal. For instance, according to a YouGov ...

Diabetes silently damages eyes by weakening retinal blood vessels, leading to vision loss through conditions like retinopathy ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Diabetic retinopathy is the leading cause of blindness in ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

Scientists say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier, an important boundary that regulates the flow of nutrients, waste and ...

Use of empagliflozin (Jardiance) was not linked to a lower risk of incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase-4 (DPP-4) inhibitors among patients with type 2 ...